Centiva Capital’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,085
Closed -$74.8K 1805
2026
Q1
$74.8K Buy
+16,085
New +$92.1K ﹤0.01% 1440
2025
Q3
Sell
-46,815
Closed -$332K 1067
2025
Q2
$332K Buy
+46,815
New +$349K 0.01% 1155
2025
Q1
Sell
-35,111
Closed -$444K 1519
2024
Q4
$444K Sell
35,111
-9,826
-22% -$118K 0.01% 900
2024
Q3
$504K Buy
44,937
+31,047
+224% +$363K 0.01% 1243
2024
Q2
$178K Sell
13,890
-6,110
-31% -$93.2K ﹤0.01% 1720
2024
Q1
$313K Buy
+20,000
New +$315K 0.01% 1220
2021
Q4
Sell
-89,516
Closed -$1.28M 1164
2021
Q3
$1.28M Buy
+89,516
New +$1.28M 0.08% 248

Other funds holding OSG

Centiva Capital's OSG Position: Q2 2026 in Review

Centiva Capital sold out of Octave Specialty Group (OSG) in Q2 2026, closing a stake of 16,085 shares — an estimated $74.8K sold.

Centiva Capital first reported a position in OSG in Q3 2021 and held it in 7 quarters. The position peaked at $1.28M in Q3 2021. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • Centiva Capital reported no remaining Octave Specialty Group position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 16,085 Octave Specialty Group shares in Q2 2026, an estimated $74.8K.
  • Centiva Capital first reported a position in Octave Specialty Group in Q3 2021 and held it in 7 quarters.
  • Centiva Capital's Octave Specialty Group position peaked at $1.28M in Q3 2021.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.